Zusammenfassung
Die Liste der Krankheiten, unter den Patienten im Alter leiden, ist lang und unübersichtlich. Einige Alterskrankheiten mit überragender Bedeutung und ihre Therapie werden in diesem Kapitel beschrieben: Schlaganfall, Herzinsuffizienz, koronare Herzkrankheit, Hypertonus, Vorhofflimmern, Osteoporose, Frakturen und Alterstraumatologie, Amputationen und Prothesenversorgung, Demenz, Delir, Depression, Gerontostomatologie, Diabetes mellitus, rheumatologischen Erkrankungen sowie Infektionen mit Problemkeimen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
DVO (2014) S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e.V.: Prophylaxe, Diagnostik und Therapie der Osteoporose bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen. http://www.dvosteologie.org/uploads/Leitlinie%202014/DVO-Leitlinie%20Osteoporose%202014%20Kurzfassung%20und%20Langfassung%2018.%2009.%202014.pdf
McClung MR, GrauerA, Boonen S, et al. (2014) Romosozumab in Postmenopausal Women with Low Bone Mineral Density. N Engl J Med 370:412–20
Lotinun S, Kiviranta R, Matsubara T et al. (2013) Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation J Clin Invest 123(2):666–681
Hadji P. Bock O. Resch H et al. (2013) Reduction of fracture risk with denosumab among women with osteoporosis with or without need for treatment according to DVO 2009 guideline. A subgroup analysis of the FREEDOM trial. Osteologie 22: 39–45
Hadji P, Zanchetta JR, Russo L et al. (2012) The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporos Int 23(8):2141–50
Bone HG, Chapurlat R, Brandi ML et al. (2012) The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Bone Miner Res 27(3):694–701
Giangregorio LM, Macintyre NJ, Thabane L, Skidmore CJ, Papaioannou A (2013) Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev 31;1:CD008618
Anderson PA, Froyshteter AB, Tontz WL Jr. (2013) Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J Bone Miner Res 28(2):372–82
Walsh JB, Lems WF, Karras D et al. (2012) Effectiveness of teriparatide in women over 75 years of age with severe osteoporosis: 36-months results from the European Forsteo Observational Study (EFOS). Calcif Tissue Int 90: 373–383
Jakob F, Oertel H, Langdahl B et al. (2012) Effects of Teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteop Observational Study. Eur J Endocrinol 166: 87–97
Jǿrgensen TS, Hansen AH, Sahlberg M et al. (2014) Falls and comorbidity: The pathway to fractures. Scand J Public Health 42; 287–294
Ohta H, Uemura Y, Nakamura T et al. (2014) Serium 25-hydroxyvitamin-D level als an indipendent determinant of quality of life in osteoporosis with a high risk for fracture. Clin Ther 36: 225–235
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Neubart, R. et al. (2015). Typische Erkrankungen des Alters. In: Neubart, R. (eds) Repetitorium Geriatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48210-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-48210-0_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48209-4
Online ISBN: 978-3-662-48210-0
eBook Packages: Medicine (German Language)